Central effects of the potent and highly selective μ opioid antagonist (CTOP) in mice
- 10 June 1988
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 150 (3), 355-360
- https://doi.org/10.1016/0014-2999(88)90018-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Design and synthesis of conformationally constrained somatostatin analogs with high potency and specificity for .mu. opioid receptorsJournal of Medicinal Chemistry, 1986
- Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptorsLife Sciences, 1986
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Somatostatin analogs with affinity for opiate receptors in rat brain binding assayPeptides, 1985
- Oxytocin and a C-terminal derivative (Z-prolyl-d-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brainNeuropharmacology, 1985
- On the mode of action of an oxytocin derivative (Z-Pro-D-Leu) on morphine-dependence in miceNeuropharmacology, 1981
- Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptorsEuropean Journal of Pharmacology, 1976
- Fluorescenzmikroskopische Untersuchungen über den Stofftransport zwischen Ventrikelliquor und GehirnCell and tissue research, 1964